18-44950031-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015559.3(SETBP1):c.691G>C(p.Val231Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.201 in 1,614,022 control chromosomes in the GnomAD database, including 33,960 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_015559.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.187 AC: 28410AN: 152094Hom.: 2739 Cov.: 32
GnomAD3 exomes AF: 0.191 AC: 47951AN: 250928Hom.: 5025 AF XY: 0.197 AC XY: 26737AN XY: 135640
GnomAD4 exome AF: 0.203 AC: 296307AN: 1461810Hom.: 31222 Cov.: 41 AF XY: 0.204 AC XY: 148357AN XY: 727206
GnomAD4 genome AF: 0.187 AC: 28413AN: 152212Hom.: 2738 Cov.: 32 AF XY: 0.187 AC XY: 13919AN XY: 74418
ClinVar
Submissions by phenotype
not provided Benign:4
- -
- -
- -
- -
not specified Benign:2
- -
This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 27. Only high quality variants are reported. -
Schinzel-Giedion syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at